PARISH FIELDS PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: D82031 | DISS, IP22 4WG
Showing results 151-200 of 592
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Betahistine hydrochloride | 263 | 19.0K | £633 | +10.2% ▲ |
| Lorazepam | 251 | 7,644 | £2.3K | +76.1% ▲ |
| Sotalol hydrochloride | 249 | 15.7K | £523 | +254.1% ▲ |
| 247 | 114.3K | £888 | +170.9% ▲ | |
| Sitagliptin | 241 | 6,804 | £484 | -38.2% ▼ |
| Sodium valproate | 239 | 46.4K | £4.1K | -24.9% ▼ |
| Bumetanide | 235 | 12.7K | £1.3K | -13.7% ▼ |
| Cyclizine hydrochloride | 235 | 13.8K | £485 | +45.7% ▲ |
| Clonazepam | 234 | 16.0K | £2.9K | +50.2% ▲ |
| 230 | 25.4K | £749 | -16.8% ▼ | |
| Enalapril maleate | 228 | 7,756 | £284 | +26.9% ▲ |
| Nefopam hydrochloride | 228 | 19.8K | £814 | +101.6% ▲ |
| Clobetasone butyrate | 228 | 10.2K | £1.3K | +11.7% ▲ |
| 225 | 232 | £1.2K | -4.7% ▼ | |
| 222 | 222 | £9.5K | -28.5% ▼ | |
| Carvedilol | 220 | 9,716 | £361 | +93.9% ▲ |
| Prochlorperazine maleate | 218 | 11.9K | £657 | +7.9% ▲ |
| Quinine sulfate | 217 | 6,104 | £1.1K | -25.0% ▼ |
| Hypromellose | 213 | 2,690 | £570 | +60.7% ▲ |
| Fluticasone furoate | 213 | 223 | £1.5K | +10.0% ▲ |
| 211 | 3,430 | £736 | -15.4% ▼ | |
| Bezafibrate | 207 | 7,354 | £1.4K | +284.3% ▲ |
| Fluticasone propionate (Nasal) | 207 | 521 | £2.3K | +42.2% ▲ |
| Pericyazine | 201 | 13.9K | £5.7K | +81.9% ▲ |
| Olanzapine | 195 | 5,292 | £796 | -47.4% ▼ |
| Pancreatin | 193 | 37.3K | £10.5K | +73.6% ▲ |
| Brinzolamide | 193 | 1,300 | £974 | +48.6% ▲ |
| Melatonin | 192 | 16.0K | £6.4K | -42.3% ▼ |
| Rabeprazole sodium | 190 | 7,594 | £1.0K | +268.4% ▲ |
| Ispaghula husk | 189 | 7,648 | £1.3K | +43.5% ▲ |
| Nifedipine | 187 | 10.4K | £2.9K | -0.2% vs avg |
| Ticagrelor | 185 | 10.4K | £10.0K | +117.6% ▲ |
| 183 | 50.3K | £891 | -30.6% ▼ | |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 180 | 5,329 | £571 | +17.9% ▲ |
| Biphasic isophane insulin | 180 | 1,259 | £5.3K | +61.3% ▲ |
| Calcipotriol | 180 | 14.6K | £6.9K | +5.7% ▲ |
| Biphasic insulin aspart | 177 | 1,447 | £8.3K | +74.3% ▲ |
| Paroxetine hydrochloride | 174 | 6,069 | £913 | -6.8% ▼ |
| Tolterodine | 174 | 5,656 | £784 | +17.0% ▲ |
| Baclofen | 174 | 38.4K | £741 | -13.1% ▼ |
| Vortioxetine | 172 | 3,964 | £3.7K | +147.8% ▲ |
| Timolol and bimatoprost | 172 | 2,466 | £2.5K | +13.3% ▲ |
| Fluticasone furoate/vilanterol | 169 | 169 | £3.9K | +9.2% ▲ |
| Terbinafine hydrochloride | 168 | 4,902 | £2.2K | +171.8% ▲ |
| Lithium carbonate | 167 | 7,020 | £1.0K | +31.6% ▲ |
| Alogliptin | 165 | 4,593 | £4.0K | -34.9% ▼ |
| Tamoxifen citrate | 165 | 4,948 | £523 | +100.4% ▲ |
| Dexamethasone | 160 | 810 | £498 | -6.9% ▼ |
| Fusidic acid | 158 | 2,910 | £383 | +23.7% ▲ |
| Oxybutynin | 156 | 7,686 | £872 | -18.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.